Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma.

The Journal of Experimental Medicine
Sergio A QuezadaJames P Allison

Abstract

Interference with inhibitory immunological checkpoints controlling T cell activation provides new opportunities to augment cancer immunotherapies. Whereas cytotoxic T lymphocyte-associated antigen-4 blockade has shown promising preclinical and clinical results, therapeutic CD4(+)CD25(+) T reg cell depletion has failed to consistently enhance immune-based therapies. Using B16/BL6, a transplantable murine melanoma model, we show a dichotomy between the effects of T reg cell depletion on tumor rejection dependent on whether depletion occurs before (prophylactic) or after (therapeutic) tumor engraftment. Failure to promote rejection with therapeutic depletion is not related to lack of T reg cell depletion, to elimination of CD25(+) effector T cells, or to a failure to enhance systemic antitumor T cell responses, but correlates with failure of effector cells to infiltrate the tumor and increase the intratumor ratio of effector T cell/T reg cell. Finally, systemic antitumor responses generated upon therapeutic T reg cell depletion are significantly stronger than those generated in the presence of T reg cells, and are capable of eliciting rejection of established tumors after transfer into immunoablated recipients receiving combinatio...Continue Reading

References

Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Mar 22, 1996·Science·D R LeachJ P Allison
Jun 1, 1996·The Journal of Experimental Medicine·M F Krummel, J P Allison
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·A A HurwitzJ P Allison
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Eduard RyschichRuth Ganss
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
Jun 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Giao Q PhanSteven A Rosenberg
Aug 20, 2003·The Journal of Experimental Medicine·Willem W OverwijkNicholas P Restifo
Sep 16, 2004·European Journal of Immunology·Ruth GanssGünter J Hämmerling
Sep 24, 2004·The Journal of Experimental Medicine·Mary Jo TurkAlan N Houghton
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul A AntonyNicholas P Restifo
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomás AlvaroMiguel A Piris
May 11, 2005·The Journal of Experimental Medicine·Anne M ErcoliniElizabeth M Jaffee
Jun 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Amit A LugadeEdith M Lord
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ettore BiagiMalcolm Brenner
Nov 26, 2005·The Journal of Clinical Investigation·Jens DannullJohannes Vieweg
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eiichi SatoKunle Odunsi
Feb 9, 2006·Current Opinion in Immunology·Karl S PeggsJames P Allison
Jun 17, 2006·The Journal of Clinical Investigation·Sergio A QuezadaJames P Allison
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keith L KnutsonMary L Disis
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel J PowellSteven A Rosenberg
Dec 1, 2006·Nature Immunology·Jeong M KimAlexander Y Rudensky
Jan 11, 2007·The Journal of Experimental Medicine·Bin ZhangHans Schreiber
Feb 23, 2007·International Journal of Cancer. Journal International Du Cancer·Karsten MahnkeAlexander Herrmann Enk
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric J SmallJames P Allison
May 4, 2007·The Journal of Clinical Investigation·Tyler J Curiel
May 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kutlu G ElpekHaval Shirwan
Jun 6, 2007·The Journal of Clinical Investigation·Carl H June
Jun 9, 2007·The Journal of Clinical Investigation·Masahisa JinushiGlenn Dranoff
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric J SmallJonathan W Simons
Jul 28, 2007·The Journal of Clinical Investigation·Chrystal M PaulosNicholas P Restifo

❮ Previous
Next ❯

Citations

Jan 18, 2011·Cancer Immunology, Immunotherapy : CII·Kevin DurganYvette E Latchman
Apr 6, 2011·Cancer Immunology, Immunotherapy : CII·Jianda YuanJedd D Wolchok
Apr 11, 2012·Cancer Immunology, Immunotherapy : CII·Gwendoline Rahir, Muriel Moser
Apr 25, 2012·Pathology Oncology Research : POR·Hajnalka JókaiPéter Holló
Oct 30, 2012·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·C TanchotE Tartour
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Duane A Mitchell, John H Sampson
Sep 21, 2013·Nature Immunology·Dalia BurzynDiane Mathis
Sep 24, 2011·Nature Reviews. Immunology·Gregory T Motz, George Coukos
Feb 17, 2010·The Journal of Experimental Medicine·Ying XiePaul Andrew Antony
Dec 5, 2012·The Journal of Experimental Medicine·Jing NiAdelheid Cerwenka
Sep 23, 2009·Current Opinion in Oncology·Khashayarsha KhazaiePhilipp Beckhove
Feb 9, 2012·Clinical & Developmental Immunology·Theodore S JohnsonBernard L Maria
Feb 19, 2009·Cancer Research·Taylor H SchreiberEckhard R Podack
May 3, 2012·Cancer Research·Andrea FacciabeneGeorge Coukos
Sep 20, 2011·The Journal of Clinical Investigation·Daniel T FisherSharon S Evans
Sep 5, 2012·The Journal of Clinical Investigation·Maria Grazia RuoccoSandra Demaria
Oct 16, 2012·The Journal of Clinical Investigation·Yong LuQing Yi
Sep 22, 2010·PLoS Biology·Emily CorseJames P Allison
Apr 17, 2012·PloS One·Ulrike TrägerAnna Katharina Simon
Aug 17, 2011·Immunotherapy·Sergio A Quezada, Karl S Peggs
Oct 17, 2013·Cancer Immunology, Immunotherapy : CII·Alexandr V BazhinSvetlana Karakhanova
Apr 26, 2014·The Journal of Clinical Investigation·Rajarshi BhadraImtiaz A Khan
Apr 16, 2014·Immunology and Cell Biology·Yannick BulliardJennifer L Brogdon
Sep 10, 2011·Cellular and Molecular Life Sciences : CMLS·Arthur Mortha, Andreas Diefenbach
Dec 17, 2015·Nature Reviews. Clinical Oncology·Peter SavasSherene Loi
Nov 15, 2011·Expert Opinion on Pharmacotherapy·Xiang-Yang WangPaul B Fisher

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
confocal microscopy
flow
flow cytometry

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.